Birafox 250 mg is a selective anti-cancer drug whose active agent is Abiraterone. It is indicated for melanoma, non-small cell lung cancer, and some other cancers with BRAF V600 mutations. Abiraterone 250mg tab is combined with the drug trametinib for the best efficacy. The drug is given in two doses daily orally on an empty stomach. Birafox 250 mg Product Information About Birafox 250mg Cancer Medication Birafox is a kinase inhibitor that specifically inhibits the MAPK signaling pathway in cancer cells. It acts by preventing the functioning of the aberrant BRAF protein that is responsible for the excessive proliferation of cancer cells. The drug is selective for the mutant types of BRAF, such as V600E, V600K, and V600D. What does Birafox treat? Birafox 250mg mainly targets the following conditions: Metastatic Melanoma: Unresectable or metastatic melanoma with BRAF V600E or V600K mutations detected by an FDA-approved test. Non-Small Cell Lung Cancer: Metastatic NSCLC with BRAF V600E mutation as first-line or subsequent therapy. Anaplastic Thyroid Cancer: Locally advanced or metastatic ATC with BRAF V600E mutation and no satisfactory locoregional options. Adjuvant Melanoma Treatment: After complete surgical resection of Stage III melanoma with BRAF mutations. Solid Tumors: Unresectable or metastatic solid tumors with BRAF V600E mutation in patients who progressed after prior treatment. What is the Mechanism of Birafox 250mg? Birafox prevents the action of the BRAF protein that is responsible for cell division in the tumor. In the case of the BRAF V600 mutation, the abnormal BRAF is involved in cancer development. The mutation causes the cell to acquire an abnormal character and to divide without limit. Blocking the BRAF activity helps cancer to grow and spread more slowly. It binds to the ATP-binding pocket of the mutated BRAF competitively. This inhibition decreases MEK and ERK phosphorylation, thus arresting the cell cycle. How Should I Use Birafox 250mg? The appropriate dosage a patient must take is always to be decided by a professional from the healthcare sector, according to the: Specific type of cancer BRAF status mutation Patient’s reaction to treatment and tolerance, Any use of other cancer drugs at the same time Patient’s health The regular dose is taken in two 150mg doses, with the next one being taken after 12 hours of taking the previous one. You can take it before and after a meal. Keep treating as long as the patient is getting benefits from it. What Is The Price Of Birafox 250 mg? What Are The Possible Side Effects? Birafox 250 mg may cause side effects in some patients. Common Side Effects: Fever and chills (very common) Headache Skin rash and thickening Hair loss Nausea and vomiting Joint pain and arthralgia Fatigue and weakness Cough Loss of appetite Constipation or diarrhea Serious Side Effects (Rare): New skin cancers such as cutaneous squamous cell carcinoma Severe bleeding in stomach, bowel, or brain Heart problems and decreased cardiac function Eye problems such as uveitis and vision changes Severe fever requiring hospitalization Blood clots and deep vein thrombosis Kidney problems Severe allergic reactions Liver toxicity Combination Therapy Effects: Fever occurs more often when trametinib is added Cardiac toxicity monitoring will be needed with the combination Eye issues are more prevalent with MEK inhibitor combinations Overall, better survival despite increased toxicity In case of a serious side effect occurrs, do not hesitate to seek help from a physician right away. Who Should Avoid Birafox Treatment? There are some patients that will have to be careful or use Birafox 250 mg with utmost caution: Absolute Contraindications: Wild-Type BRAF: BRAF V600 mutation is necessary for the use of this drug in patients, as it will have no effect otherwise. Known Hypersensitivity: Serious allergic reactions to Abiraterone or any of the tablet’s components in the past. Type 1 Diabetes with DKA: Possible complications in case of diabetes that is not well controlled. Medical Conditions Requiring Caution: G6PD Deficiency: Hemolytic anemia with strict monitoring may be the consequence during treatment. Heart Problems: Cardiac conditions that need monitoring of ejection fraction beforehand and during therapy. Kidney Disease: Drug clearance is affected by decreased kidney function. thus monitoring is needed. Liver Disease: Drug metabolism is affected by hepatic impairment, hence dose adjustments are necessary. Pregnancy: Fetal damage could occur – effective contraception is needed during and after treatment. Breastfeeding: It is not recommended during the therapy and also for two weeks after the last dose. Eye Problems: History of retinal diseases that demand ophthalmologic monitoring. Interacting Drugs: CYP3A4 or CYP2C8 Inducers: Rifampin, phenytoin, and carbamazepine greatly reduce the effectiveness of Birafox. CYP3A4 or CYP2C8 Inhibitors: Ketoconazole, nefazodone, elevating Birafox levels and toxicity. Warfarin: May cause prothrombin time changes that necessitate close INR monitoring. Hormonal Contraceptives: Might be less effective, thus alternative birth control methods may be necessary. Other Cancer Medications: Trametinib is usually given together, but specific dosing protocols are required. How Should I Store Birafox? Store in room temperature below 30°C Moisture and light should not be in contact. Keep it our of reach of children It is not permitted to use it past the date of expiration. Do not change the container. Dispose of the product according to local regulations. Important Safety Information Before treatment is started, the tumor has to be tested for the BRAF V600 mutation, and it has to be positive. Skin examinations will be required before, during, and after the treatment. Regular monitoring for the development of new cancers is necessary. Daily taking at the same time is needed for consistency. Any unusual bleeding should be reported immediately. Blood pressure should be monitored regularly. Eye examinations are recommended during treatment. Effective contraception is required during therapy. Frequently Asked Questions About Birafox 250mg 1. How long does treatment typically last? Treatment continues as long as you benefit from it and side effects remain tolerable. For adjuvant melanoma after surgery, treatment typically lasts 12 months unless disease returns. Median duration varies by cancer type. 2. What happens if I miss a dose? Take missed dose as soon as you remember if less than 6 hours until next scheduled dose. If closer to next dose, skip it and resume normal schedule. Never double dose to make up. 3. Why is BRAF testing important? Medication only works in cancers with specific BRAF V600 mutations. Without this mutation, treatment will not be effective. Testing identifies which patients will benefit from therapy. 4. Can I take it with food? No, take on empty stomach. Food significantly affects absorption. Take at least 1 hour before or 2 hours after eating. Maintain consistent timing daily. 5. What makes combination therapy better? Combining with trametinib (MEK inhibitor) blocks cancer growth pathway at two points. This improves survival significantly compared to single drug therapy despite increased side effects like fever. Disclaimer: This product information is for educational purposes only and should not replace professional medical advice. Always consult qualified healthcare providers before starting treatment.
